InsidersTradesSigma
Track the 인투셀 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 인투셀 has logged 3 reports. Market capitalisation: €254.9bn. The latest transaction was reported on 5 June 2026 (Purchase). Among the most active insiders: 이향숙. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
인투셀 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se enfoca en el desarrollo de terapias innovadoras y soluciones de salud.